From time to time, a firm will retire its logo and replace it with a newer version. This prompted us to wonder: why would a company, whose logo is instantly recognizable, want to make this change? To answer the question, we might have conducted a little informal research, ferreted out the company’s graphic aspirations, […]
When the legal industry hit a wall during the last recession, its reaction was typical of most businesses: laying off workers, postponing new hires, and devising alternative payment structures. Such quick fixes made no one happy, as legal work continued to move in-house and clients demanded services that went unbilled. The situation (“Is Big Law […]
On June 11, 2015, the New York Times reported that a small Chinese company had produced 100 doses of an Ebola drug that closely mirrored a drug patented by a U.S. drug-maker and for which the U.S. government held a patent on one of the constituent antibodies. According to the article, a U.S. government official […]
Participants: Paul England, Taylor & Wessing (Moderator); Johannes Karcher, Head of Task Force, EU-Patent and Unified Patent Court, Federal Ministry of Justice and Consumer Protection, Berlin; Coordinator of the Legal Working Group of the Preparatory Committee for the establishment of the Unified Patent Court (Speaker); Mr. Justice Colin Birss, Chancery Division, High Court, London (Panelist); Sir Robin Jacob, University […]
This session broadly addressed the development of IP law in China, focusing in particular on how Chinese bureaucrats and judges approach “the rule of law”; the difficulties and opportunities faced by Western companies seeking to protect their IP in China; and the strategies of Chinese regulators to create an IP regime consistent with parochial economic […]
